Navigation Links
Increased Heart Attack Risk From Celebrex,Vioxx

CELEBREX (celecoxib capsules) is used for relief of the pain and inflammation of osteoarthritis and adult rheumatoid arthritis. By effectively reducing the pain, inflammation and stiffness of arthritis, celebrex can help you through the day with activities like standing, walking or climbing stairs, and through the night while sitting or lying in bed.

Since their introduction in 1999, the drugs, which are known technically as COX-2 inhibitors, have been among // America's best-selling prescription pharmaceuticals. One of them, Celecoxib, sold as Celebrex, was the sixth leading prescription drug used by 14 million people last year. The other COX-2 inhibitor is Rofecoxib, sold as Vioxx.

The drugs are popular because they provide the same pain- killing effects as aspirin and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen, but with less chance of causing ulcers and intestinal bleeding.

Aspirin inhibits two closely related cyclooxygenase enzymes, COX-1 and COX-2. These new drugs specifically inhibit only the COX-2 (which is involved in pain and inflammation) while not affecting the first (which is involved in protecting lining of the stomach).

Celebrex, was recently approved by the Food and Drug Administration, FDA. The popular pain-killers Celebrex and Vioxx may slightly increase a person's risk of having a heart attack, according to an analysis of clinical studies of these 'super aspirin' drugs.


'"/>




Page: 1

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Allergy Risk Increased by Kerosene Use
3. Fewer teeth & Increased Ischemic Stroke risk
4. Young Smokers at Increased Risk Of Developing a Heart Attack
5. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
6. Asbestos Exposure Associated With An Increased Risk For Autoimmune Disease
7. Schizophrenics On Medication At An Increased Risk For Developing Diabetes
8. Diabetics Found To Be At An Increased Risk Of Developing Cancer
9. Increased Risk For Venous Thrombosis In Cancer Patients
10. Increased risk of common infections in patients suffering from diabetes
11. Infertility Associated With Increased Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
Breaking Medicine Technology: